<DOC>
	<DOCNO>NCT01001403</DOCNO>
	<brief_summary>This study intend see effect nafamostat attenuation postreperfusion syndrome ( PRS ) frequently occur liver transplantation .</brief_summary>
	<brief_title>Effect Nafamostat Postreperfusion Syndrome ( PRS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nafamostat</mesh_term>
	<criteria>&gt; = 18 year old schedule undergo liver transplantation Previous history pulmonary , cardiovascular , renal disease Previous history allergic reaction nafamostat</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>